[
  {
    "ts": null,
    "headline": "5 Dividend Growth Stocks to Boost Your Portfolio",
    "summary": "Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.",
    "url": "https://finnhub.io/api/news?id=432c4d7779f37ee9fae3b540f9fc6914948307db9500150bde02bd3b271954f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755612960,
      "headline": "5 Dividend Growth Stocks to Boost Your Portfolio",
      "id": 136430463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.",
      "url": "https://finnhub.io/api/news?id=432c4d7779f37ee9fae3b540f9fc6914948307db9500150bde02bd3b271954f3"
    }
  },
  {
    "ts": null,
    "headline": "Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=314add31ec53f41ce3aa8072a24bc21c5a72e458d7a6af6f2886669f26aa4e96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755611101,
      "headline": "Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio",
      "id": 136430556,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=314add31ec53f41ce3aa8072a24bc21c5a72e458d7a6af6f2886669f26aa4e96"
    }
  },
  {
    "ts": null,
    "headline": "5 Must-Read Analyst Questions From Cardinal Health’s Q2 Earnings Call",
    "summary": "Cardinal Health’s second quarter results were met with a significant negative market reaction, largely due to flat sales and a notable miss on adjusted EBITDA versus Wall Street expectations. Management cited robust demand in pharmaceutical distribution and growth in specialty services, but also acknowledged that individually small, unexpected expenses and ongoing cost pressures weighed on the bottom line. CEO Jason Hollar highlighted operational efficiencies and the impact of recent acquisition",
    "url": "https://finnhub.io/api/news?id=deadb198e8a763f72816207153a68d737f67b55d19288f853a0bddcc45aaee06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755581446,
      "headline": "5 Must-Read Analyst Questions From Cardinal Health’s Q2 Earnings Call",
      "id": 136417314,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health’s second quarter results were met with a significant negative market reaction, largely due to flat sales and a notable miss on adjusted EBITDA versus Wall Street expectations. Management cited robust demand in pharmaceutical distribution and growth in specialty services, but also acknowledged that individually small, unexpected expenses and ongoing cost pressures weighed on the bottom line. CEO Jason Hollar highlighted operational efficiencies and the impact of recent acquisition",
      "url": "https://finnhub.io/api/news?id=deadb198e8a763f72816207153a68d737f67b55d19288f853a0bddcc45aaee06"
    }
  }
]